Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Hunter

Showing results (761-770 of 774) with videos related to

Pageof 78
Sort By:
Nucleic Acids Research|June 26, 2003
ELM server: A new resource for investigating short functional sites in modular eukaryotic proteinsPål Puntervoll, Rune Linding, Christine Gemünd, et al.
Contact in Context|May 5, 2025
Near-Infrared Spectrometry as a Tool for Screening Meropenem for QualityJames T Isaacs, Philip J Almeter, Aaron N Hunter, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 27, 2023
Screening for quality with process analytical technology in a health-system pharmacy: A primerPhilip J Almeter, James T Isaacs, Aaron N Hunter, et al.
Contact in Context|January 8, 2024
Assessment of Vecuronium Quality Using Near-Infrared SpectrometryJames T Isaacs, Philip J Almeter, Aaron N Hunter, et al.
Journal of Medicinal Chemistry|June 1, 2001
2-Amino-6-arylsulfonylbenzonitriles as non-nucleoside reverse transcriptase inhibitors of HIV-1J H Chan, J S Hong, R N Hunter, et al.
Contact in Context|May 22, 2024
Application of Near-Infrared Spectroscopy for Screening of Chlorothiazide Sodium VialsJames T Isaacs, Philip J Almeter, Aaron N Hunter, et al.
Contact in Context|December 23, 2024
Potential Process Control Issues with VasopressinJames T Isaacs, Philip J Almeter, Aaron N Hunter, et al.
Science (New York, N.Y.)|January 6, 2001
Prevention of chemotherapy-induced alopecia in rats by CDK inhibitorsS T Davis, B G Benson, H N Bramson, et al.
ACS Medicinal Chemistry Letters|August 20, 2015
Design of Potent and Orally Active GPR119 Agonists for the Treatment of Type II DiabetesPing Liu, Zhiyong Hu, Byron G DuBois, et al.
Journal of Pharmaceutical Innovation|June 9, 2022
FDA Approaches in Monitoring Drug Quality, Forces Impacting the Drug Quality, and Recent Alternative Strategies to Assess Quality in the US Drug SupplyPhilip J Almeter, James T Isaacs, Aaron N Hunter, et al.
Pageof 78

Showing results (761-770 of 774) with videos related to

Sort By:
Pageof 78
Nucleic Acids Research|June 26, 2003
ELM server: A new resource for investigating short functional sites in modular eukaryotic proteinsPål Puntervoll, Rune Linding, Christine Gemünd, et al.
Contact in Context|May 5, 2025
Near-Infrared Spectrometry as a Tool for Screening Meropenem for QualityJames T Isaacs, Philip J Almeter, Aaron N Hunter, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 27, 2023
Screening for quality with process analytical technology in a health-system pharmacy: A primerPhilip J Almeter, James T Isaacs, Aaron N Hunter, et al.
Contact in Context|January 8, 2024
Assessment of Vecuronium Quality Using Near-Infrared SpectrometryJames T Isaacs, Philip J Almeter, Aaron N Hunter, et al.
Journal of Medicinal Chemistry|June 1, 2001
2-Amino-6-arylsulfonylbenzonitriles as non-nucleoside reverse transcriptase inhibitors of HIV-1J H Chan, J S Hong, R N Hunter, et al.
Contact in Context|May 22, 2024
Application of Near-Infrared Spectroscopy for Screening of Chlorothiazide Sodium VialsJames T Isaacs, Philip J Almeter, Aaron N Hunter, et al.
Contact in Context|December 23, 2024
Potential Process Control Issues with VasopressinJames T Isaacs, Philip J Almeter, Aaron N Hunter, et al.
Science (New York, N.Y.)|January 6, 2001
Prevention of chemotherapy-induced alopecia in rats by CDK inhibitorsS T Davis, B G Benson, H N Bramson, et al.
ACS Medicinal Chemistry Letters|August 20, 2015
Design of Potent and Orally Active GPR119 Agonists for the Treatment of Type II DiabetesPing Liu, Zhiyong Hu, Byron G DuBois, et al.
Journal of Pharmaceutical Innovation|June 9, 2022
FDA Approaches in Monitoring Drug Quality, Forces Impacting the Drug Quality, and Recent Alternative Strategies to Assess Quality in the US Drug SupplyPhilip J Almeter, James T Isaacs, Aaron N Hunter, et al.
Pageof 78